36 related articles for article (PubMed ID: 17546274)
1. Cardiovascular adverse events associated with smoking-cessation pharmacotherapies.
Sharma A; Thakar S; Lavie CJ; Garg J; Krishnamoorthy P; Sochor O; Arbab-Zadeh A; Lichstein E
Curr Cardiol Rep; 2015 Jan; 17(1):554. PubMed ID: 25410148
[TBL] [Abstract][Full Text] [Related]
2. Effects of tobacco smoke exposure in childhood on atopic diseases.
Ciaccio CE; Gentile D
Curr Allergy Asthma Rep; 2013 Dec; 13(6):687-92. PubMed ID: 24057650
[TBL] [Abstract][Full Text] [Related]
3. Effect of self-administered auricular acupressure on smoking cessation--a pilot study.
Leung L; Neufeld T; Marin S
BMC Complement Altern Med; 2012 Feb; 12():11. PubMed ID: 22373002
[TBL] [Abstract][Full Text] [Related]
4. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation.
Jorenby DE; Leischow SJ; Nides MA; Rennard SI; Johnston JA; Hughes AR; Smith SS; Muramoto ML; Daughton DM; Doan K; Fiore MC; Baker TB
N Engl J Med; 1999 Mar; 340(9):685-91. PubMed ID: 10053177
[TBL] [Abstract][Full Text] [Related]
5. Bupropion sustained release added to group support for smoking cessation in schizophrenia: a new randomized trial and a meta-analysis.
Weiner E; Ball MP; Buchholz AS; Gold JM; Evins AE; McMahon RP; Buchanan RW
J Clin Psychiatry; 2012 Jan; 73(1):95-102. PubMed ID: 21535998
[TBL] [Abstract][Full Text] [Related]
6. A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia.
Evins AE; Cather C; Culhane MA; Birnbaum A; Horowitz J; Hsieh E; Freudenreich O; Henderson DC; Schoenfeld DA; Rigotti NA; Goff DC
J Clin Psychopharmacol; 2007 Aug; 27(4):380-6. PubMed ID: 17632223
[TBL] [Abstract][Full Text] [Related]
7. A comparison of sustained-release bupropion and placebo for smoking cessation.
Hurt RD; Sachs DP; Glover ED; Offord KP; Johnston JA; Dale LC; Khayrallah MA; Schroeder DR; Glover PN; Sullivan CR; Croghan IT; Sullivan PM
N Engl J Med; 1997 Oct; 337(17):1195-202. PubMed ID: 9337378
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of sustained-release bupropion in the treatment of smoker patients with cardiovascular disease.
Issa JS; Perez GH; Diament J; Zavattieri AG; de Oliveira KU
Arq Bras Cardiol; 2007 Apr; 88(4):434-40. PubMed ID: 17546274
[TBL] [Abstract][Full Text] [Related]
9. Review of bupropion for smoking cessation.
Richmond R; Zwar N
Drug Alcohol Rev; 2003 Jun; 22(2):203-20. PubMed ID: 12850907
[TBL] [Abstract][Full Text] [Related]
10. Bupropion: a review of its use in the management of smoking cessation.
Holm KJ; Spencer CM
Drugs; 2000 Apr; 59(4):1007-24. PubMed ID: 10804045
[TBL] [Abstract][Full Text] [Related]
11. Smoking cessation interventions for smokers with current or past depression.
van der Meer RM; Willemsen MC; Smit F; Cuijpers P
Cochrane Database Syst Rev; 2013 Aug; (8):CD006102. PubMed ID: 23963776
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
